SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-081932
Filing Date
2022-12-22
Accepted
2022-12-22 07:00:47
Documents
1
Period of Report
2022-12-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea170735-6k_regencellbio.htm 6-K 11357
  Complete submission text file 0001213900-22-081932.txt   12446
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 221479705
SIC: 2833 Medicinal Chemicals & Botanical Products